by Eric Christianson | Jul 26, 2023 | Cardiovascular Medication and Disease State Clinical Pearls
Atorvastatin and rosuvastatin are generic cholesterol medications that are widely used to lower LDL. Both of these medications frequently show up in the top 10 most frequently used medications. I wanted to provide a comparison of atorvastatin versus rosuvastatin to...
by Eric Christianson | Apr 9, 2023 | Cardiovascular Medication and Disease State Clinical Pearls
Bempedoic acid, also known as Nexletol, is a once-daily medication used in patients with increased atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia who are requiring additional LDL-C lowering previously on a maximally...
by Eric Christianson | Nov 27, 2022 | Clinical Guideline Updates For Pharmacists
The Framingham risk score has been the primary method of determining a patient’s 10-year risk of cardiovascular disease. Scores such as this take into account a patient’s specific risk factors including age, gender, systolic blood pressure, total cholesterol,...
by Eric Christianson | Oct 13, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
Fibrates are a type of amphipathic carboxylic acid that treat hypertriglyceridemia. They work by reducing the liver’s production of VLDL particles that carry triglycerides to tissues and accelerating the body’s removal of triglycerides. Due to this mechanism of...
by Eric Christianson | Sep 26, 2021 | Medication and Disease State Clinical Pearls For Pharmacists
Ezetimibe (Zetia) is a medication used to lower cholesterol. More specifically, this medication is used in clinical practice to lower LDL and help get patients to a target goal. If you recall from your pharmacology classes, ezetimibe inhibits the absorption of...
